Ambry, Agilent Ink Target Enrichment Alliance | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics will use Agilent Technologies' SureSelect Target Enrichment System for the exome sequencing services it provides for its customers, the firms announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.